International audienceNatural miniproteins (e.g., animal toxins, protease inhibitors, defensins) can express specific and powerful biological activities by using a stable and minimal (<80 amino acids) structural motif. Artificial activities have been designed on these miniscaffolds by transferring previously identified protein active sites into regions structurally compatible with the site and permissive for sequence mutations. These newly designed miniproteins, presenting a specific and high activity within a small size and well-defined three-dimensional structure, represent novel tools in biology, biotechnology, and medical sciences, and are also useful intermediates to develop new therapeutic agents. The different steps used to design an...
A MAJOR challenge in protein design is to create stable scaffolds into which tailored functions can ...
The de novo design of artificial metalloproteins from first-principles is a powerful strategy with w...
De novo protein design holds promise for creating small stable proteins with shapes customized to bi...
International audienceProtein-protein interacting surfaces are usually large and intricate, making t...
Protein of small size, mini protein, containing 30 to 80 amino acid residues are particularly attrac...
Biomolecular scaffolds were engineered by genetically fusing robust miniproteins in a sequence, like...
Small protein domains represent basic building blocks of naturally occurring proteins. Many of them ...
This work focuses on designing specific miniprotein interactions using computational models and then...
International audienceMiniprotein binders hold a great interest as a class of drugs that bridges the...
Macromolecular structures represent an interesting starting point for the design and synthesis of sm...
The present invention pertains to the use of a small domain of T1 lipase as a scaffold protein for t...
The antiviral activity of CD4 miniproteins was evaluated as potential HIV microbicides, using releva...
A classical approach to treating prostate cancer uses antagonist ligands - so-called anti-androgens,...
Artificial counterparts for proteins can serve in a wealth of applications such as catalysis, signal...
We recently described the design and chemical synthesis of the minibody, a 61-residue metal binding ...
A MAJOR challenge in protein design is to create stable scaffolds into which tailored functions can ...
The de novo design of artificial metalloproteins from first-principles is a powerful strategy with w...
De novo protein design holds promise for creating small stable proteins with shapes customized to bi...
International audienceProtein-protein interacting surfaces are usually large and intricate, making t...
Protein of small size, mini protein, containing 30 to 80 amino acid residues are particularly attrac...
Biomolecular scaffolds were engineered by genetically fusing robust miniproteins in a sequence, like...
Small protein domains represent basic building blocks of naturally occurring proteins. Many of them ...
This work focuses on designing specific miniprotein interactions using computational models and then...
International audienceMiniprotein binders hold a great interest as a class of drugs that bridges the...
Macromolecular structures represent an interesting starting point for the design and synthesis of sm...
The present invention pertains to the use of a small domain of T1 lipase as a scaffold protein for t...
The antiviral activity of CD4 miniproteins was evaluated as potential HIV microbicides, using releva...
A classical approach to treating prostate cancer uses antagonist ligands - so-called anti-androgens,...
Artificial counterparts for proteins can serve in a wealth of applications such as catalysis, signal...
We recently described the design and chemical synthesis of the minibody, a 61-residue metal binding ...
A MAJOR challenge in protein design is to create stable scaffolds into which tailored functions can ...
The de novo design of artificial metalloproteins from first-principles is a powerful strategy with w...
De novo protein design holds promise for creating small stable proteins with shapes customized to bi...